GGrantIndex
Sort

50,496 grants matching lung cancer

Viral Interface with an Interferon-Induced Gene

$463,541
Nancy C. Reich · State University New York Stony Brook · R01 · FY2016 · AI

Viral Interface with an Interferon-Induced Gene

$463,541
Nancy C. Reich · State University New York Stony Brook · R01 · FY2015 · AI

Viral Interface with an Interferon-Induced Gene

$463,541
Nancy C. Reich · State University New York Stony Brook · R01 · FY2017 · AI

CereTom CT for use with a microPET scanner for preclinical PET/CT imaging

$463,521
Jonathan Paul James Carney · University Of Pittsburgh At Pittsburgh · S10 · FY2009 · RR

E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma

$463,441
Pawan Sharma · Thomas Jefferson University · R01 · FY2024 · HL

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

$463,415
Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2019 · CA

Project 4: Therapeutic Targeting of Replication Stress Vulnerabilities in Small Cell Lung Cancer

$463,389
Lauren Averett Byers · Ut Southwestern Medical Center · P50 · FY2021 · CA

Mechanisms in Perinatal Carcinogenesis

$463,355
Lucy M Anderson · Basic Sciences · Z01 · FY2007 · CA

Chemoprevention of Prostate Cancer, HDAC Inhibition, and DNA Methylation

$463,297
Emily Ho · Texas A&M University Health Science Ctr · P01 · FY2014 · CA

Project-002

$463,293
Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2021 · CA

Integrated analyses of cancers harboring STK11 vs. TSC1/2 vs. PTEN Loss

$463,273
David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2014 · CA

MERTK/AXL dual inhibitors provide novel treatment for cancer by targeting tumor cells and activating anti-tumor immunity

$463,267
Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Genetics of Tobacco and Alcohol Related Cancers

$463,264
International Agency For Res On Cancer · R01 · FY2003 · CA

Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer

$463,244
Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2018 · CA

Molecular Test for Inherited Mutations in Breast Cancer

$463,209
Mark Lim · Ambergen, Inc · R44 · FY2007 · CA

Molecular Test for Inherited Mutations in Breast Cancer

$463,209
Mark Lim · Ambergen, Inc · R44 · FY2008 · CA

Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection

$463,182
Jie Sun · University Of Virginia · R01 · FY2022 · AG

Human Leukemia Growth Inhibition by a Novel Retinoid

$463,144
Joseph A Fontana · Wayne State University · R01 · FY2008 · CA

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

$463,136
Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA

Mechanisms by which LSD1 Promotes Neuroendocrine Differentiation and Small Cell Lung Cancer

$463,135
Matthew Gilbert Oser · Dana-Farber Cancer Inst · R37 · FY2023 · CA

Causes and Consequences of Acid pH in Tumors

$463,130
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA

Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis

$463,093
Agata A Exner · Case Western Reserve University · R01 · FY2022 · EB

Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis

$463,093
Agata A Exner · Case Western Reserve University · R01 · FY2023 · EB

Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma

$463,075
Kirk Seward · Mercator Medsystems, Inc. · R42 · FY2012 · CA

Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC)on Immunotherapy

$463,067
Despina Kontos · Columbia University Health Sciences · R01 · FY2024 · CA